Cat.#: ACPP-1778
| Despition | HSD17B10 Human Recombinant |
| SIZE | 2 µg |
| Sequence | Met-Phe-Pro-Thr-Ser. |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1040 | Recombinant Mouse Eph Receptor A2 Protein (6×His Tag) (AC1040) | 50 µg | inquiry |
| ACPP-1719 | Human FDFT1 Protein (AC1719) | 2 µg | inquiry |
| ACPP-1576 | Human YWHAE Protein (AC1576) | 5 µg | inquiry |
| ACPP-1584 | Human Human Leptin Protein (AC1584) | 100 µg | inquiry |
| ACPP-1184 | MSX1 Blocking Peptide (AC1184) | 250 µg | inquiry |
| ACPP-1625 | Human POMC Protein (AC1625) | 2 µg | inquiry |
| ACPP-1287 | Dopamine Receptor D1 Blocking Peptide (AC1287) | 250 µg | inquiry |
| ACPP-1358 | CRMP3 Blocking Peptide (AC1358) | 250 µg | inquiry |
| ACPP-1663 | Human DUSP6 Protein (AC1663) | 2 µg | inquiry |
| ACPP-1372 | Exendin 4 (AC1372) | 20 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.